Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 1321561)

Published in Am J Epidemiol on May 15, 1992

Authors

C Maden1, A M Beckmann, D B Thomas, B McKnight, K J Sherman, R L Ashley, L Corey, J R Daling

Author Affiliations

1: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.

Articles citing this

Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91

Oral sex and the transmission of viral STIs. Sex Transm Infect (1998) 2.50

Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J (2006) 2.18

Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol (2005) 1.81

Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70

Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health (2007) 1.65

Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med (2009) 1.52

Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital (2009) 1.05

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol (2011) 1.01

Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med (2008) 0.97

Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther (2008) 0.91

Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol (2003) 0.91

Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol (2011) 0.91

Incidence of invasive cancers following carcinoma in situ of the cervix. Br J Cancer (1996) 0.85

A history of allergies is associated with reduced risk of oral squamous cell carcinoma. Cancer Causes Control (2012) 0.82

Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium. Am J Epidemiol (2016) 0.81

Oral Sex and HPV: Population Based Indications. Indian J Otolaryngol Head Neck Surg (2012) 0.80

Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck. Oncol Lett (2012) 0.80

The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin Med Insights Oncol (2011) 0.76

Family history of cancer, personal history of medical conditions and risk of oral cavity cancer in France: the ICARE study. BMC Cancer (2013) 0.76

Articles by these authors

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09

Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89

Mucosal shedding of human herpesvirus 8 in men. N Engl J Med (2000) 6.59

Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Plasma viremia in human immunodeficiency virus infection. N Engl J Med (1989) 5.73

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A (1998) 5.48

Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet (1991) 5.42

Chronic fatigue in adolescents. Pediatrics (1991) 5.24

Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med (1999) 4.81

Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54

Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA (1991) 4.49

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39

Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21

Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol (1981) 4.10

Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med (1995) 4.03

Effect of a ban on carrying firearms on homicide rates in 2 Colombian cities. JAMA (2000) 3.91

Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med (1996) 3.88

Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med (1994) 3.83

BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83

The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73

The acquisition of herpes simplex virus during pregnancy. N Engl J Med (1997) 3.73

Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71

A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66

Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51

Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol (1999) 3.48

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med (1987) 3.42

Modeling plasma virus concentration during primary HIV infection. J Theor Biol (2000) 3.40

Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) (2001) 3.36

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med (1996) 3.35

Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33

Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32

Infections with herpes simplex viruses (1). N Engl J Med (1986) 3.26

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet (2000) 3.22

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA (1998) 3.03

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98

Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood (1999) 2.97

History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92

Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest (1998) 2.85

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest (1984) 2.85

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med (1995) 2.83

Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis (2001) 2.79

Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74

Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74

Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis (1998) 2.72

Estimating the risk of breast cancer in relation to the interval since last term pregnancy. Epidemiology (1997) 2.72

A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71

Randomized trial comparing traditional Chinese medical acupuncture, therapeutic massage, and self-care education for chronic low back pain. Arch Intern Med (2001) 2.67

Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64

Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62

Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61

Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med (1999) 2.58

Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58

Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55

Chronic fatigue. A prospective clinical and virologic study. JAMA (1990) 2.54

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet (1994) 2.53

Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51

Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol (1983) 2.50

Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides. J Biol Chem (1969) 2.43

Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43

Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol (1993) 2.42

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA (1998) 2.42

Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41

Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38